You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,752,504


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,752,504
Title: System for monitoring therapy during calibration
Abstract:A system for continuing the monitoring of certain gases delivered to a patient during the administration of nitric oxide to provide therapy to the patient. The nitric oxide is controlled by a electrically operated valve that is operated by means of an electrical signal from a CPU. At times when the various gas monitors are being calibrated, the normal alarms based upon those gas monitors are conventionally disabled during that calibration time. With the present invention, the electrical signal to the electrically operated valve is detected at the time the system goes into a calibration cycle and that detected electrical signal is used to establish limits such as a upper limit and a lower limit. Therefore, when the electrical signal to the valve is thereafter monitored and its value exceeds either of those limits, the overall nitric oxide delivery system will activate an alarm to alert the user of an abnormal condition. Thus an alarm system is present even when the various gas monitors are otherwise taken out of the system during their calibration.
Inventor(s): Bathe; Duncan P. L. (Madison, WI)
Assignee: Ohmeda Inc. (Liberty Corner, NJ)
Application Number:08/764,569
Patent Claim Types:
see list of patent claims
Device; Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 5,752,504

Introduction

United States Patent 5,752,504, titled "System for monitoring therapy during calibration," is a significant patent in the field of medical technology, particularly in the administration and monitoring of nitric oxide therapy. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Title and Abstract

The patent, issued on May 19, 1998, describes a system designed to monitor therapy during the calibration of gas delivery systems, specifically those used in the administration of nitric oxide to patients. The system ensures continuous monitoring of the gases delivered, enhancing patient safety and the efficacy of the therapy[5].

Scope of the Patent

Technical Field

The patent falls within the technical field of medical devices, specifically those related to respiratory therapy and gas delivery systems. It addresses the need for accurate and continuous monitoring of gas concentrations during medical treatments.

Background of the Invention

The background section of the patent highlights the importance of precise gas delivery in medical treatments, particularly for nitric oxide therapy, which is used to treat conditions such as hypoxic respiratory failure. The existing systems at the time had limitations in terms of continuous monitoring and calibration, which this invention aimed to address[5].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the system's components and their functions:

  • Claim 1: Describes the overall system for monitoring therapy during calibration, including a gas delivery system, a calibration device, and a monitoring device.
  • Claim 2: Details the calibration device and its role in adjusting the gas concentration.
  • Claim 3: Outlines the monitoring device and its function in continuously measuring the gas concentration.

Dependent Claims

Dependent claims further specify the details of the system, such as the types of sensors used, the data processing algorithms, and the user interface for displaying the monitored data.

Patent Landscape

Prior Art and References

The patent cites several prior art documents, including U.S. patents and other international patents related to gas delivery and monitoring systems. These references indicate the state of the art at the time of the invention and help to distinguish the novel aspects of the patented system[5].

Competing Patents

Other patents in the same field, such as U.S. Patent 5,573,733 and U.S. Patent 5,674,381, also deal with gas delivery and monitoring systems. These patents highlight the competitive landscape and the ongoing innovations in this area.

Global Patent Family

To understand the global reach of this invention, it is essential to look at the patent family, which includes related applications filed in other countries. Tools like the Global Dossier provided by the USPTO can help in identifying the patent family and understanding the international protection of this invention[1].

Claim Coverage and Scope Concepts

Claim Coverage Matrix

A Claim Coverage Matrix, as described in patent analytics, can help in understanding which patents and claims are actively protecting the intellectual property related to this invention. This matrix categorizes patents by claims and scope concepts, providing a clear picture of the coverage and any gaps or opportunities[3].

Scope Concepts

The scope concepts related to this patent would include high-value claims that are crucial for the current technology, medium-value claims indicating potential future directions, and low-value claims that may not be worth maintaining. This categorization helps in strategic decision-making regarding patent maintenance and future development[3].

Practical Applications and Impact

Clinical Use

The system described in the patent has significant clinical applications, particularly in intensive care units where nitric oxide therapy is commonly used. The continuous monitoring and calibration ensure that patients receive the correct dosage of nitric oxide, improving treatment outcomes and patient safety.

Industry Impact

This patent has contributed to the advancement of medical technology in gas delivery systems. It has set a standard for continuous monitoring and calibration, influencing subsequent innovations in this field.

Key Takeaways

  • Continuous Monitoring: The patent emphasizes the importance of continuous monitoring of gas concentrations during medical treatments.
  • Calibration: The system's calibration device ensures accurate gas delivery, which is critical for effective therapy.
  • Patent Landscape: The patent is part of a broader landscape of innovations in gas delivery and monitoring systems.
  • Global Protection: Understanding the global patent family is crucial for assessing the international protection of this invention.
  • Claim Coverage: Analyzing the claim coverage matrix helps in identifying gaps and opportunities in intellectual property protection.

FAQs

Q: What is the primary purpose of United States Patent 5,752,504?

A: The primary purpose is to describe a system for monitoring therapy during the calibration of gas delivery systems, specifically for nitric oxide therapy.

Q: How does the patent improve existing gas delivery systems?

A: The patent improves existing systems by providing continuous monitoring and calibration, ensuring accurate and safe gas delivery.

Q: What are the key components of the system described in the patent?

A: The key components include a gas delivery system, a calibration device, and a monitoring device.

Q: How does the patent fit into the broader patent landscape?

A: The patent is part of a competitive landscape of innovations in gas delivery and monitoring systems, with several prior art references and related patents.

Q: What tools can be used to analyze the claim coverage of this patent?

A: Tools such as the Claim Coverage Matrix and scope concepts analysis can be used to understand the claim coverage and identify gaps or opportunities.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Canadian Patents Database - Patent 2671029 Summary: https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2671029/summary.html?wbdisable=true
  3. Patent Analytics | Intellectual Property Law: https://www.slwip.com/services/patent-analytics/
  4. United States Patent - googleapis.com: https://patentimages.storage.googleapis.com/ec/bc/7d/f78a723967e65a/US10695523.pdf
  5. System for monitoring therapy during calibration - Patent US ...: https://pubchem.ncbi.nlm.nih.gov/patent/US5752504

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,752,504

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,752,504

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2211748 ⤷  Subscribe
European Patent Office 0839546 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.